hydralazine has been researched along with Erythrocytosis in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CLARK, TW | 1 |
| EWER, RW | 1 |
| Rüegger, M | 1 |
| Medici, TC | 1 |
| Malgor, LA | 1 |
| Fisher, JW | 1 |
3 other studies available for hydralazine and Erythrocytosis
| Article | Year |
|---|---|
HEREDITARY SPHEROCYTOSIS AND POLYCYTHEMIA.
Topics: Ankyrins; Bloodletting; Chlorothiazide; Drug Therapy; Geriatrics; Humans; Hydralazine; Hypertension; | 1965 |
[New therapies for cor pulmonale?].
Topics: Bloodletting; Humans; Hydralazine; Hypertension, Pulmonary; Hypoxia; Iron; Lung Diseases, Obstructiv | 1983 |
Antagonism of angiotensin by hydralazine on renal blood flow and erythropoietin production.
Topics: Angiotensin II; Animals; Blood Flow Velocity; Blood Pressure; Dogs; Drug Synergism; Erythropoietin; | 1969 |